11 – 20 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
- Contribution to journal › Article
-
Mark
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
- Contribution to journal › Article
-
Mark
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
- Contribution to journal › Scientific review
- 2020
-
Mark
Cerebrospinal fluid tau fragment correlates with tau PET : a candidate biomarker for tangle pathology
- Contribution to journal › Article
-
Mark
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
- Contribution to journal › Article
- 2019
-
Mark
Parkinson's disease : Evolution of cognitive impairment and CSF Aβ1-42 profiles in a prospective longitudinal study
- Contribution to journal › Article
-
Mark
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
- Contribution to journal › Article
-
Mark
Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults
(2019) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 39(44). p.8788-8797
- Contribution to journal › Article
-
Mark
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia : An elusive quest
- Contribution to journal › Article
-
Mark
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
- Contribution to journal › Article
